3 ms·
Too much hype, too little proof. Until then, this is pure shit, nothing more. SV BS spreading from software to Biotech/Pharma.
by shiven 10y ago
Too much hype, too little proof. Until then, this is pure shit, nothing more.
SV BS spreading from software to Biotech/Pharma.